[Latest] Global Clinical Informatics Market Size/Share Worth USD 962.41 Billion by 2035 at a 13.36% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

BETA Technologies, Inc. Announces First Quarter 2026 Results

Wyndham Hotels & Resorts Digital Transformation Strategy Analysis Report 2026: Technology Focus and Initiatives, Partnerships and Acquisitions, ICT Budget & Contracts, Tech Ecosystem

Danaher Digital Transformation Strategy Analysis Report 2026: Technology Focus and Initiatives, Partnerships and Acquisitions, ICT Budget & Contracts, Tech Ecosystem

State Bank of India Digital Transformation Strategy Analysis Report 2026: Technology Focus and Initiatives, Partnerships and Acquisitions, ICT Budget & Contracts, Tech Ecosystem

Despite Middle East tensions, tariffs remain top political risk concern, according to latest Willis Political Risk Survey

UGI International Commences Senior Notes Offering

Basware Invoice Lifecycle Management Now Available on SAP® Store

Schemes become legally effective

Monthly Cash Flow Report - April 2026

ZTE Hosts 2026 Broadband User Congress in São Paulo, under the Theme "Monetize Your Intelligent Broadband"

Galaxy Entertainment Group Selected Unaudited Q1 2026 Financial Data

Hi-View Resources Completes Comprehensive Wildlife Management Plan For Toodoggone Properties

Herbal Dispatch Expands House of Brands Strategy with Launch of Northern Drip Extracts

Orion Animal Health receives US FDA approval for Tessie® (tasipimidine oral solution) for the treatment of noise aversion and separation anxiety in dogs

Elbit Systems of America Awarded $212 Million Delivery Order From The U.S. Army For Enhanced Night Vision Goggle - Binocular

Visa Flexible Credential Brings More Flexible Ways to Pay to Zilch Cardholders in the UK

Nokia launches agentic AI for home and broadband networks

Telenor partners with Verdane to build a global IoT leader

New Data Analyses Presented at Heart Failure 2026 Demonstrate Robust and Consistent Clinical Benefit of Vutrisiran as a First-Line Treatment Option Across ATTR-CM Patient Populations, Including Patients with a High Disease Burden